TY - GEN A1 - Yan, Robert A1 - Friemel, Martin A1 - Aloisi, Claudia A1 - Huynen, Martijn A1 - Taylor, Ian A. A1 - Leimkühler, Silke A1 - Pastore, Annalisa T1 - The eukaryotic-specific Isd11 is a complex- orphan protein with ability to bind the prokaryotic IscS T2 - Postprints der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe N2 - The eukaryotic protein Isd11 is a chaperone that binds and stabilizes the central component of the essential metabolic pathway responsible for formation of iron-sulfur clusters in mitochondria, the desulfurase Nfs1. Little is known about the exact role of Isd11. Here, we show that human Isd11 (ISD11) is a helical protein which exists in solution as an equilibrium between monomer, dimeric and tetrameric species when in the absence of human Nfs1 (NFS1). We also show that, surprisingly, recombinant ISD11 expressed in E. coli co-purifies with the bacterial orthologue of NFS1, IscS. Binding is weak but specific suggesting that, despite the absence of Isd11 sequences in bacteria, there is enough conservation between the two desulfurases to retain a similar mode of interaction. This knowledge may inform us on the conservation of the mode of binding of Isd11 to the desulfurase. We used evolutionary evidence to suggest Isd11 residues involved in the interaction. T3 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe - 551 KW - sulfur cluster formation KW - Escherichia coli KW - cysteine desulfurase KW - interacting protein KW - bacterial frataxin KW - statistical-model KW - biogenesis KW - biosynthesis KW - NFS1 KW - deficiency Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-411906 SN - 1866-8372 IS - 551 ER - TY - GEN A1 - Sas, Claudia A1 - Müller, Frank A1 - Kappel, Christian A1 - Kent, Tyler V. A1 - Wright, Stephen I. A1 - Hilker, Monika A1 - Lenhard, Michael T1 - Repeated inactivation of the first committed enzyme underlies the loss of benzaldehyde emission after the selfing transition in Capsella T2 - Postprints der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe N2 - The enormous species richness of flowering plants is at least partly due to floral diversification driven by interactions between plants and their animal pollinators [1, 2]. Specific pollinator attraction relies on visual and olfactory floral cues [3-5]; floral scent can not only attract pollinators but also attract or repel herbivorous insects [6-8]. However, despite its central role for plant-animal interactions, the genetic control of floral scent production and its evolutionary modification remain incompletely understood [9-13]. Benzenoids are an important class of floral scent compounds that are generated from phenylalanine via several enzymatic pathways [14-17]. Here we address the genetic basis of the loss of floral scent associated with the transition from outbreeding to selfing in the genus Capsella. While the outbreeding C. grandiflora emits benzaldehyde as a major constituent of its floral scent, this has been lost in the selfing C. rubella. We identify the Capsella CNL1 gene encoding cinnamate: CoA ligase as responsible for this variation. Population genetic analysis indicates that CNL1 has been inactivated twice independently in C. rubella via different novel mutations to its coding sequence. Together with a recent study in Petunia [18], this identifies cinnamate: CoA ligase as an evolutionary hotspot for mutations causing the loss of benzenoid scent compounds in association with a shift in the reproductive strategy of Capsella from pollination by insects to self-fertilization. T3 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe - 904 KW - benzyl alcohol-dehydrogenase KW - floral scent KW - recent speciation KW - petunia flowers KW - genus capsella KW - evolution KW - biosynthesis KW - fragrance KW - purification KW - pollinators KW - benzaldehyde KW - selfing syndrome KW - shepherd’s purse KW - cinnamate:CoA ligase Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-438018 SN - 1866-8372 IS - 904 SP - 3313 EP - 3319 ER - TY - THES A1 - Reyna González, Emmanuel T1 - Engineering of the microviridin post-translational modification enzymes for the production of synthetic protease inhibitors T1 - Manipulation der posttranslationalen Modifikationsenzyme von Microviridin zur Herstellung synthetischer Proteaseinhibitoren N2 - Natural products and their derivatives have always been a source of drug leads. In particular, bacterial compounds have played an important role in drug development, for example in the field of antibiotics. A decrease in the discovery of novel leads from natural sources and the hope of finding new leads through the generation of large libraries of drug-like compounds by combinatorial chemistry aimed at specific molecular targets drove the pharmaceutical companies away from research on natural products. However, recent technological advances in genetics, bioinformatics and analytical chemistry have revived the interest in natural products. The ribosomally synthesized and post-translationally modified peptides (RiPPs) are a group of natural products generated by the action of post-translationally modifying enzymes on precursor peptides translated from mRNA by ribosomes. The great substrate promiscuity exhibited by many of the enzymes from RiPP biosynthetic pathways have led to the generation of hundreds of novel synthetic and semisynthetic variants, including variants carrying non-canonical amino acids (ncAAs). The microviridins are a family of RiPPs characterized by their atypical tricyclic structure composed of lactone and lactam rings, and their activity as serine protease inhibitors. The generalities of their biosynthetic pathway have already been described, however, the lack of information on details such as the protease responsible for cleaving off the leader peptide from the cyclic core peptide has impeded the fast and cheap production of novel microviridin variants. In the present work, knowledge on leader peptide activation of enzymes from other RiPP families has been extrapolated to the microviridin family, making it possible to bypass the need of a leader peptide. This feature allowed for the exploitation of the microviridin biosynthetic machinery for the production of novel variants through the establishment of an efficient one-pot in vitro platform. The relevance of this chemoenzymatic approach has been exemplified by the synthesis of novel potent serine protease inhibitors from both rationally-designed peptide libraries and bioinformatically predicted microviridins. Additionally, new structure-activity relationships (SARs) could be inferred by screening microviridin intermediates. The significance of this technique was further demonstrated by the simple incorporation of ncAAs into the microviridin scaffold. N2 - Naturstoffe und ihre Derivate waren schon immer eine Quelle von Leitstrukturen. Insbesondere haben bakterielle Verbindungen eine wichtige Rolle bei der Arzneimittelentwicklung gespielt, zum Beispiel im Bereich der Antibiotika. Die Abnahme von Entdeckungen neuer Leitstrukturen aus natürlichen Quellen und die Hoffnung, neue Leitstrukturen in großen Bibliotheken medikamentenähnlicher Verbindungen zu finden, welche auf spezifische molekulare Ziele gerichtet sind und mithilfe kombinatorischer Chemie erstellt wurden, trieben die Pharmaunternehmen weg von der Naturstoffforschung. Allerdings haben moderne technologische Fortschritte in der Genetik, der Bioinformatik und der analytischen Chemie das Interesse an Naturstoffen wiederbelebt. Die ribosomal synthetisierten und posttranslational modifizierten Peptide (RiPPs) sind eine Gruppe von Naturstoffen, die durch das Einwirken posttranslational modifizierender Enzymen auf Präkursorpeptide entstehen, welche ihrerseits aus mRNA durch Translation an den Ribosomen hervorgehen. Die durch viele der Enzyme aus RiPP Biosynthesewege gezeigte große Substrat- Promiskuität führte zur Erzeugung hunderter neuartiger synthetischer und halbsynthetischer Varianten, einschließlich Varianten mit nicht-kanonischen Aminosäuren. Die Microviridine sind eine Familie von RiPPs, die durch ihre atypische trizyklische Struktur aus Lacton- und Lactamringen und ihre Aktivität als Serin-Protease-Inhibitoren gekennzeichnet sind. Die Grundlagen ihres Biosyntheseweges sind bereits beschrieben worden, aber wesentliche Fragestellungen, zum Beispiel die für die Spaltung des Leader-Peptids vom zyklischen Core- Peptid verantwortliche Protease betreffend, sind weitgehend ungeklärt und erschweren die schnelle und kostengünstige Herstellung neuer Microviridinvarianten. In der vorliegenden Arbeit wurde das Wissen über die durch Leader-Peptid Aktivierung von Enzymen aus anderen RiPP-Familien auf die Microviridinfamilie extrapoliert, wodurch es möglich wurde, die Notwendigkeit eines Leader-Peptids zu umgehen. Diese Besonderheit erlaubt nunmehr, die Microviridin-Biosynthese-Enzyme für die Herstellung von neuartigen Varianten durch die Etablierung einer effizienten in vitro Synthese-Plattform auszunutzen. Die Relevanz dieses chemoenzymatischen Ansatzes wurde durch die Synthese von neuen potenten Serin-Protease- Inhibitoren aus sowohl rational gestalteten Peptidbibliotheken als auch bioinformatisch vorhergesagten Microviridinen veranschaulicht. Darüber hinaus wurden durch das Screenen von Microviridinzwischenprodukten neue Struktur-Funktionsbeziehungen abgeleitet. Die Bedeutung dieser Technik wurde durch den einfachen Einbau von nicht-kanonischen Aminosäuren in das Microviridin-Gerüst weiter demonstriert. KW - RiPP KW - microviridin KW - biosynthesis KW - natural products KW - peptide KW - protease inhibitor KW - Biosynthese KW - Naturstoffe KW - cyanobacteria KW - Cyanobakterien KW - Microviridin KW - Protease-Inhibitoren Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-406979 ER -